Pfizer ' s $225K Price for Heart Drug Tafamidis Slammed Pfizer ' s $225K Price for Heart Drug Tafamidis Slammed

The current price hinders access for those most likely to benefit and slows clinical advances in the management of ATTR-CM, a ' not-so-rare ' condition, experts say.Medscape Medical News

Source: Medscape Cardiology Headlines - January 16, 2020 Category: Cardiology Tags: Cardiology News Source Type: news